ENZALUTAMIDE for Bone cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 213 adverse event reports in the FDA FAERS database where ENZALUTAMIDE was used for Bone cancer.
Most Reported Side Effects for ENZALUTAMIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Fatigue | 8,891 | 18.1% | 594 | 1,115 |
| Death | 6,680 | 13.6% | 6,677 | 702 |
| Malignant neoplasm progression | 4,696 | 9.5% | 1,482 | 695 |
| Prostatic specific antigen increased | 3,731 | 7.6% | 321 | 463 |
| Asthenia | 3,589 | 7.3% | 386 | 785 |
| Drug ineffective | 3,468 | 7.0% | 235 | 275 |
| Hot flush | 3,144 | 6.4% | 119 | 262 |
| Decreased appetite | 3,069 | 6.2% | 413 | 811 |
| Nausea | 2,898 | 5.9% | 264 | 554 |
| Dizziness | 2,776 | 5.6% | 201 | 503 |
| Diarrhoea | 2,470 | 5.0% | 209 | 473 |
| Underdose | 2,017 | 4.1% | 393 | 320 |
| Back pain | 1,997 | 4.1% | 185 | 356 |
| Arthralgia | 1,821 | 3.7% | 114 | 243 |
| Constipation | 1,629 | 3.3% | 136 | 296 |
Other Indications for ENZALUTAMIDE
Prostate cancer (25,954)
Product used for unknown indication (9,434)
Hormone-refractory prostate cancer (8,881)
Prostate cancer metastatic (3,171)
Metastases to bone (439)
Neoplasm prostate (401)
Neoplasm malignant (297)
Hormone-dependent prostate cancer (289)
Prostate cancer stage iv (208)
Prostatic specific antigen increased (199)
Other Drugs Used for Bone cancer
PALBOCICLIB (493)
LENALIDOMIDE (342)
CABOZANTINIB S-MALATE (328)
DENOSUMAB (219)
PAZOPANIB (182)
ERLOTINIB (174)
CAPECITABINE (143)
BEVACIZUMAB (140)
POMALIDOMIDE (114)
ABEMACICLIB (90)